World s First Patient Enrolled in SELUTION4DeNovo DEB IDE Trial streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technology, today announced.
A new device called bioadaptable, as opposed to bioabsorbable, was noninferior to a widely used drug eluting stent, and associated with several vessel functional improvements, in the BIOADAPTER trial.